Refine results:

Clear all

A technician innoculates a series of agar plates with bacteria.

Opinion | 23 April 2019

We ignore the disaster in the antibiotics market at our peril by Jeremy Farrar

There is no viable path for new drugs, however valuable they are to society.

illustration of influenza bacteria

Opinion | 1 March 2019

Vaccines work – for superbugs too by Ed Whiting

There's a vital set of tools to help us tackle the threat of superbugs that we're not using to their full potential. Vaccines.

Woman wearing MEG scanner

News | 20 December 2018

10 ways remarkable research is protecting health

During 2018 we've featured stories about trailblazing research by people we support. Here are some highlights.

Illustration showing overlapping circles

News | 3 December 2018

Second global call to action against drug-resistant infections

Wellcome has co-hosted a second global event, in Ghana, to help drive pioneering action to stop the rise and spread of superbugs.

A petri dish covered with colonies of E. Coli

News | 27 June 2018

New antibiotic approved for drug-resistant infections

A new antibiotic to treat drug-resistant infections, developed with support from Wellcome, has been approved for patient use in the USA.

Enterobacteriaceae

News | 22 March 2018

First Japanese company joins CARB-X partnership

Pharmaceutical company Shionogi is the first Japanese company to join CARB-X, Wellcome’s antibiotic development partnership.

Man in car studying map.

News | 13 March 2018

Wellcome's goals: support global research to tackle global challenges

In March 2017, Wellcome announced five ambitious goals to support research globally. Today we look at what we have achieved so far and what we are working towards in 2018.

Young person drinking water from a tap in Pakistan

Opinion | 9 March 2018

The story of a superbug from genome to advocacy by Elizabeth Klemm

A ‘typhoid superbug’ in Pakistan has been in headlines around the world. Researchers identified a typhoid strain that has become resistant to multiple antibiotics.

Professor Sharon Peacock

News | 30 January 2018

Global intelligence on superbugs vital to stop antibiotic resistance

Wellcome is bringing together a new, international expert group, SEDRIC. Professor Sharon Peacock, the group’s Chair, explains why it’s necessary and what it aims to do.

A doctor examines the x-ray of the chest of a patient with TB

News | 13 October 2017

Global pledges to speed up action on superbugs

Wellcome is investing £2.4 million in a new project to track the global impact of superbugs as part of our ongoing efforts to help address this urgent global health threat.

Pages